MiMedx Group, Inc (MDXG)

Etorro trading 970x250
MiMedx Group, Inc (MDXG) Logo

About MiMedx Group, Inc

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts. The company’s patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, pressure ulcers, and burns; AmnioFix, a semi-permeable protective barrier membrane product for the treatment of wounds related to surgical procedures; EpiCord and AmnioCord that are dehydrated human umbilical cord allografts intended for homologous applications; and AmnioFill that consists of particles of connective tissue matrix derived from placental disc and placental membranes. The company’s products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia. Address: 1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062

MiMedx Group, Inc News and around…

Latest news about MiMedx Group, Inc (MDXG) common stock and company :

Next Capital Management LLC Buys Globus Medical Inc, Tesla Inc, PPG Industries Inc, Sells Apple ...
14 Jan, 2022 Yahoo! Finance

Investment company Next Capital Management LLC (Current Portfolio) buys Globus Medical Inc, Tesla Inc, PPG Industries Inc, CSG Systems International Inc, iShares Core MSCI Emerging Markets ETF, sells Apple Inc, Nuveen Floating Rate Income Fund, Blackrock Floating Rate Inc Stra Fd Inc, Nuveen Short Duration Credit Opps, JPMorgan Chase during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Next Capital Management LLC.

MDXG: New Year’s Resolutions
12 Jan, 2022 Yahoo! Finance

By John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT Key Strategic Milestones for 2022 On January 10, 2022, MiMedx Group, Inc. (NASDAQ:MDXG) reiterated its 2021 accomplishments and announced its 2022 initiatives and guidance. With the recent revelation of the shelf-life issues that obscured endpoint results from MiMedx’ recent Phase IIb KOA trial, the company plans to soon

MIMEDX Outlines Key Strategic Milestones for 2022
10 Jan, 2022 Yahoo! Finance

MIMEDX Primed to Commence Pivotal Phase 3 Clinical Study Program of micronized dehydrated Human Amnion Chorion Membrane (mdHACM) in Knee Osteoarthritis (KOA), Targeting Potential Late-2026 Commercial Launch Double-Digit Growth Objective in 2022 to be Driven by Treatment Transformation, Global Market Expansion and Ongoing Portfolio Innovation across Multimodal Placental Tissue Platform Company to Present at 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12 at 5:15 PM ET MARIE

MIMEDX to Participate at the H.C. Wainwright BioConnect Virtual Conference
04 Jan, 2022 Yahoo! Finance

MARIETTA, Ga., Jan. 04, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that Timothy R. Wright, Chief Executive Officer, Peter M. Carlson, Chief Financial Officer, and Robert B. Stein, M.D., Ph.D., Executive Vice President, Research and Development, will participate in a fireside chat at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022. The pre-recorded firesi

MiMedx Group, Inc. (NASDAQ:MDXG) Is Expected To Breakeven In The Near Future
30 Dec, 2021 Yahoo! Finance

MiMedx Group, Inc. ( NASDAQ:MDXG ) is possibly approaching a major achievement in its business, so we would like to...

Rtw Investments, Lp Buys Thermo Fisher Scientific Inc, Penumbra Inc, Tenaya Therapeutics Inc, ...
23 Dec, 2021 Yahoo! Finance

Investment company Rtw Investments, Lp (Current Portfolio) buys Thermo Fisher Scientific Inc, Penumbra Inc, Tenaya Therapeutics Inc, argenx SE, Macrogenics Inc, sells Quidel Corp, Protagonist Therapeutics Inc, MiMedx Group Inc, , Castle Biosciences Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Rtw Investments, Lp.

MIMEDX to Present at the 40th Annual J.P. Morgan Healthcare Conference
22 Dec, 2021 Yahoo! Finance

MARIETTA, Ga., Dec. 22, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced that Timothy R. Wright, Chief Executive Officer, and Peter M. Carlson, Chief Financial Officer, will present during the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12 at 5:15 PM EST. Institutional investors interested in a virtual meeting with management during the conference may reach out to their

MDXG: Pre-Interim Puzzle Solved
16 Dec, 2021 Yahoo! Finance

By John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT Investor Day On December 7, 2021, MiMedx Group, Inc. (NASDAQ:MDXG) held a Virtual Investor Day for the first time in four years. The Investor Day was held via webcast and featured a number of distinguished Key Opinion Leaders (KOLs). The primary concern since the September 13 th topline data report for Knee Osteoarthritis

MIMEDX Outlines Long-Term Value Creation Strategy at Virtual Investor Day
07 Dec, 2021 Yahoo! Finance

Company to Share Probability Values from its Knee Osteoarthritis (KOA) Study; Analyses Conducted Support Confidence in Initiation of Confirmatory Phase 3 Trials in 2022 Commercial Business Strategy Demonstrates Sustainable Double-digit Growth Potential in Multiple Underpenetrated Markets MIMEDX Increases 2021 Adjusted Net Sales Outlook to between $253 Million and $258 Million LINK: Virtual Investor Day Begins at 9:00 A.M. ET MARIETTA, Ga., Dec. 07, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Na

Peek Under The Hood: EES Has 16% Upside
30 Nov, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the WisdomTree US.

MIMEDX Announces Speakers for December 7 Investor Day
30 Nov, 2021 Yahoo! Finance

Company to Host Virtual Event on December 7, 2021 Beginning at 9:00 a.m. ET MARIETTA, Ga., Nov. 30, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or “the Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced the speakers for its upcoming virtual Investor Day that will be held on Tuesday, December 7, 2021 at 9:00 a.m. ET. Timothy R. Wright, MIMEDX Chief Executive Officer, commented, “Our team is excited to share

MIMEDX to Present at the Piper Sandler 33rd Annual Healthcare Conference
22 Nov, 2021 Yahoo! Finance

MARIETTA, Ga., Nov. 22, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Officer, and Rohit Kashyap, Ph.D., Chief Commercial Officer, will present at the Piper Sandler 33rd Annual Healthcare Conference taking place November 29 to December 2, 2021. Management’s presentation will be available to view on-demand beginn

Peer Reviewed Study Demonstrates MIMEDX Dehydrated Human Amnion Chorion Membrane (dHACM) Outperforms Standard of Care in Select Mohs Defect Reconstructions
17 Nov, 2021 Yahoo! Finance

MIMEDX PURION® Processed Placental Allografts Proved Safer Than Autologous Tissue, Reducing Infection, Scarring and Reoperation Rates MARIETTA, Ga., Nov. 17, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced publication of a peer-reviewed study in Facial Plastic Surgery & Aesthetic Medicine investigating the safety and utility of the Company’s PURION® pro

Those who invested in MiMedx Group (NASDAQ:MDXG) three years ago are up 224%
15 Nov, 2021 Yahoo! Finance

The last three months have been tough on MiMedx Group, Inc. ( NASDAQ:MDXG ) shareholders, who have seen the share price...

MDXG: Third Quarter Results
05 Nov, 2021 Yahoo! Finance

By John Vandermosten, CFA NASDAQ:MDXG READ THE FULL MDXG RESEARCH REPORT Third Quarter 2021 Financial and Operational Results On November 2, 2021, MiMedx Group, Inc. (NASDAQ:MDXG) filed its 3Q:21 Form 10-Q with the SEC and issued a press release summarizing its financial and operational results. A conference call and webcast were held the following morning to communicate additional detail to

86 Biggest Movers From Yesterday
04 Nov, 2021 FinancialContent

Gainers FAT Brands Inc. (NASDAQ: FATBB) shares gained 99.2% to settle at $15.44. FAT Brands recently announced plans to acquire ...

MIMEDX Announces Third Quarter 2021 Operating and Financial Results
02 Nov, 2021 Yahoo! Finance

Third Quarter Net Sales of $63.1 Million Versus $64.3 Million in 3Q20 Adjusted Net Sales of $62.8 Million Include a 13% Increase in Core Portfolio Sales Versus 3Q20 Year-to-Date Adjusted Net Sales Increase of 16% in Core Portfolio Sales Versus Prior Year Period Reflects Expansion in Surgical Applications Company to Host Conference Call on November 3, 2021, at 8:30 AM ET MARIETTA, Ga., Nov. 02, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry lea

MIMEDX to Participate at Upcoming Investor Conferences
02 Nov, 2021 Yahoo! Finance

MARIETTA, Ga., Nov. 02, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Officer, Peter M. Carlson, Chief Financial Officer, and Rohit Kashyap, Ph.D., Chief Commercial Officer, will be participating in the following virtual investor conferences: Credit Suisse 30th Annual Healthcare ConferenceFireside Chat: Tuesday,

Earnings Scheduled For November 2, 2021
02 Nov, 2021 FinancialContent

Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per ...

Two New Studies Demonstrate in vitro Bioactivity Potential of Micronized Dehydrated Human Amnion Chorion Membrane (mdHACM) to Prevent Pathological Processes Underlying Osteoarthritis (OA) and Tendinopathy
01 Nov, 2021 Yahoo! Finance

Figure 1 Micronized dHACM regulation of Wnt and NF-κβ signaling Data Show mdHACM Mitigates Effects of Inflammatory-Induced Degeneration in Chondrocytes, the Primary Cell Type in Cartilage; May Mitigate Vessel Formation and Repair MARIETTA, Ga., Nov. 01, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, announced two peer-reviewed studies investigating the use of microniz

MIMEDX to Host Third Quarter 2021 Operating and Financial Results Conference Call on November 3
20 Oct, 2021 Yahoo! Finance

MARIETTA, Ga., Oct. 20, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that it will report operating and financial results for the third quarter ended September 30, 2021 after the market close on Tuesday, November 2, 2021. MIMEDX management will host a webcast and conference call to review its results on Wednesday, November 3, 2021, beginning at 8:30 a

MIMEDX to Host Virtual Investor Day on December 7, 2021
14 Oct, 2021 Yahoo! Finance

MARIETTA, Ga., Oct. 14, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or “the Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that it will host a virtual Investor Day on Tuesday, December 7, 2021 beginning at 9:00 a.m. ET. The event will focus on the Company’s musculoskeletal late-stage pipeline and advanced wound care business. Further details regarding registration, presenters and format will follow. A l

Net Health Agreement with MIMEDX Streamlines Complex Insurance Benefits Verifications
13 Oct, 2021 Yahoo! Finance

Net Health, a leading provider of analytics and cloud-based software for specialty medical providers, announced today that it has added MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX") to the list of leading wound care providers that rely on Net Health® Wound Care's in-chart ordering platform, CTP Connections. Through the agreement, hospital and outpatient wound care providers can quickly and efficiently submit electronic insurance verification forms and secure approvals for MIMEDX tissue-based prod

First Week of MDXG November 19th Options Trading
05 Oct, 2021 FinancialContent

Investors in MiMedx Group Inc (MDXG) saw new options begin trading this week, for the November 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDXG options chain for the new November 19th contracts and identified one put and one call contract of particular interest.

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
16 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

12 Health Care Stocks Moving In Tuesday's Intraday Session
14 Sep, 2021 FinancialContent

Gainers Progenity (NASDAQ:PROG) shares increased by 17.0% to $1.1 during Tuesday's regular session. As of 12:30 EST, ...

Analysts See 60% Upside For The Holdings of XBI
14 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR— S&P— Biotech ETF (XBI), we found that the implied analyst target price for the ETF based upon its underlying holdings is $209.54 per unit.

72 Biggest Movers From Yesterday
14 Sep, 2021 FinancialContent

Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from ...

Noteworthy Monday Option Activity: EGHT, HEAR, MDXG
13 Sep, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in 8x8 Inc (EGHT), where a total of 38,383 contracts have traded so far, representing approximately 3.8 million underlying shares. That amounts to about 550.4% of EGHT's average daily trading volume over the past month of 697,320 shares..

Mid-Afternoon Market Update: Dow Rises Over 100 Points; Itamar Medical Shares Spike Higher
13 Sep, 2021 FinancialContent

Toward the end of trading Monday, the Dow traded up 0.38% to 34,739.18 while the NASDAQ fell 0.27% to 15,074.10. The S&P also fell, ...

MiMedx Group, Inc (MDXG) is a NASDAQ Common Stock listed in , ,

970x250